Description

2-Bromo-5,6-Dihydrothieno[2,3-C]Pyridin-7(4H)-One is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure containing bromine, sulfur, and nitrogen. This compound is of significant value in medicinal chemistry for its role as a versatile building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the development of therapeutic agents targeting central nervous system disorders and other complex diseases.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology research.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Organic Synthesis Building Block: Employed in the construction of complex fused heterocyclic systems due to its reactive bromine substituent and unique thienopyridinone core.
• Agrochemical Development: Potential application as an intermediate in the synthesis of new crop protection agents and pesticides.
• Material Science Research: Investigated for its potential use in the development of organic electronic materials and functional polymers.

Basic Information

Product Name	2-Bromo-5,6-Dihydrothieno[2,3-C]Pyridin-7(4H)-One
CAS No.	960289-03-6
Molecular Formula	C7H6BrNOS
Molecular Weight	232.10 g/mol
Synonyms	2-Bromo-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-7-one; 2-Bromo-5,6-dihydro-4H-thieno[2,3-c]pyridin-7-one; 960289-03-6; Thieno[2,3-c]pyridin-7(4H)-one, 2-bromo-5,6-dihydro-; 2-Bromothieno[2,3-c]pyridin-7(4H)-one
EINECS	Contact for details

Quality Control

Our 2-Bromo-5,6-Dihydrothieno[2,3-C]Pyridin-7(4H)-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical quality attributes. Our commitment to quality supports compliance with cGMP standards for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.